Condition
Upper Tract Urothelial Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Upper Tract Urothelial Cancer clinical trials that are recruiting, at sites in 5 countries (most in United States (2), Italy (1), Hong Kong (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Upper Tract Urothelial Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Specimen Collection for Validation of a New urine-based bladder cancer test | — | Oceanside, California and 22 other locations | Recruiting | Jun 29, 2026 |
| Robotic surgery for upper tract urothelial cancer patients | — | Taipei | Recruiting | May 23, 2025 |
| Sequential gemcitabine plus Jelmyto for favorable high-grade upper tract urothelial cancer | Phase 2 | New Brunswick, New Jersey | Recruiting | Feb 12, 2025 |
| Examining gene alterations and chemotherapy response in advanced bladder cancer | Phase 4 | Rome | Recruiting | Feb 11, 2025 |
| Registry for assessing the effects of Upper Tract Urothelial Cancer | — | Hong Kong | Recruiting | Jun 30, 2022 |
All recruiting trials (5)
-
Specimen Collection for Validation of a New urine-based bladder cancer test
This study collects urine and tumor samples from adults being evaluated or treated for urothelial cancer to validate a next‑generation sequencing platform.
-
Robotic surgery for upper tract urothelial cancer patients
This study tests whether using a special robotic system for kidney and ureter surgery can safely help patients with upper tract urothelial cancer recover better and have good outcomes.
-
Sequential gemcitabine plus Jelmyto for favorable high-grade upper tract urothelial cancer
This trial tests whether giving gemcitabine followed by Jelmyto directly into the kidney can control favorable high‑grade upper tract urothelial cancer and help people avoid kidney removal.
-
Examining gene alterations and chemotherapy response in advanced bladder cancer
This study is testing if certain gene changes can help predict how well advanced bladder cancer patients will respond to platinum-based chemotherapy treatments.
-
Registry for assessing the effects of Upper Tract Urothelial Cancer
This study is creating a registry to gather information and samples from patients with Upper Tract Urothelial Cancer to help improve understanding and treatment of the disease.
Related topics
Quick answers
How many Upper Tract Urothelial Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Italy (1 trial), Hong Kong (1 trial), Taiwan (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.